دورية أكاديمية

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial

التفاصيل البيبلوغرافية
العنوان: Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
المؤلفون: Zdenkowski, N. *, Forbes, J.F., Boyle, F.M., Kannourakis, G., Gill, P.G., Bayliss, E., Saunders, C., Della-Fiorentina, S., Kling, N., Campbell, I., Mann, G.B., Coates, A.S., Gebski, V., Davies, L., Thornton, R., Reaby, L., Cuzick, J., Green, M.
المصدر: In Annals of Oncology May 2016 27(5):806-812
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw055